Meta

Eric Lefkofsky: Revolutionizing Cancer Treatment

Cancer is one of the worst ailments that can befall someone. It is one of life’s inexplicable conditions that are too complicated to unravel — and very painful to experience.

There are thousands of different organizations trying to find a cure for cancer, but so far, none has been successful. The best we have is a treatment to try to reverse disease if it is diagnosed in time, or medication to keep a patient as comfortable as possible in case it is detected too late.

Eric Lefkofsky is one of the most recognizable names when it comes to cancer medication and research. He is a co-founder and the current Chief Executive Officer at Tempus, a company that uses technology to try to improve cancer treatment.

Eric is a serial entrepreneur, and he has founded and invested in numerous companies.

Early Life and Education

Eric Lefkofsky was born and raised in Southfield, Michigan. His family was middle class, and they led a fairly comfortable life. Eric attended Lathrup High School, graduating in 1987.

He received his graduate degree from the University of Michigan, where he graduated top of his class in 1991. Two years later, he got his Juris Doctor from the University of Michigan’s law school.

Business Career

Eric started his business career immediately after he graduated from law school. He teamed up with a friend to raise money from friends and family that enabled them to purchase clothing company in neighboring Wisconsin.

He later co-founded a company called Innerworkings, which specialized in print procurement solutions for companies. In 2005, he co-founded a transportation logistics company. The company was such a success that it was soon trading on the NASDAQ.

His latest masterpiece is Tempus — the technological and data synchronization firm that has its eyes on cancer treatment and cure. Tempus is already a hot stock. It has attracted at least $100 million in its initial stages of funding. It also has gene editing therapy, which can treat many conditions by eliminating mutations in a particular gene.